BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao J, Song X, Deng J, Lv L, Ma P, Gao B, Zhou X, Zhang Y, Xu J. Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway. FEBS Open Bio 2016;6:961-71. [PMID: 27642560 DOI: 10.1002/2211-5463.12105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Guo Y, Jiang M, Zhao X, Gu M, Wang Z, Xu S, Yue W. Cyclophilin A promotes non-small cell lung cancer metastasis via p38 MAPK. Thorac Cancer 2018;9:120-8. [PMID: 29110442 DOI: 10.1111/1759-7714.12548] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
2 Ao G, Wang Y, Qi X, Nasr B, Bao M, Gao M, Sun Y, Xie D. The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando) 2021;35:100628. [PMID: 34087553 DOI: 10.1016/j.trre.2021.100628] [Reference Citation Analysis]
3 Glowacka P, Rudnicka L, Warszawik-Hendzel O, Sikora M, Goldust M, Gajda P, Stochmal A, Blicharz L, Rakowska A, Olszewska M. The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections. Biology (Basel) 2020;9:E192. [PMID: 32731331 DOI: 10.3390/biology9080192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
4 A Abdullah A, Abdullah R, A Nazariah Z, N Balakrishnan K, Firdaus J Abdullah F, A Bala J, Mohd-Lila MA. Cyclophilin A as a target in the treatment of cytomegalovirus infections. Antivir Chem Chemother 2018;26:2040206618811413. [PMID: 30449131 DOI: 10.1177/2040206618811413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]